Recently, expression of CXCR4 was reported in primary tumors and metastatic lesions of patients with ACC both at protein level in vitro and in vivo using radiolabeled CXCR4 ligands (3, 4). This evidence concerns the gene CXCR4 and adrenal cortex carcinoma.